Several Options Remain For Cidara’s Flu Candidate After J&J Halts Development

 
• By Ayisha Sharma
  
hands holding up a paper cut-out showing arrows in different directions
Janssen Could Out-License The Asset Or Return It To Cidara • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip